- Previous Close
0.6000 - Open
0.6050 - Bid 0.6100 x 350000
- Ask 0.6150 x 325100
- Day's Range
0.6050 - 0.6100 - 52 Week Range
0.4280 - 0.6300 - Volume
3,340 - Avg. Volume
365 - Market Cap (intraday)
1.154B - Beta (5Y Monthly) 0.62
- PE Ratio (TTM)
4.69 - EPS (TTM)
0.1300 - Earnings Date Mar 25, 2025 - Mar 31, 2025
- Forward Dividend & Yield 0.04 (6.79%)
- Ex-Dividend Date Jun 12, 2024
- 1y Target Est
--
Genertec Universal Medical Group Company Limited, together with its subsidiaries, offers financing and advisory services in the People's Republic of China. It operates in two segments, Finance Business and Healthcare Business. The Finance Business segment provides direct finance leasing; sale and leaseback; factoring; operating leases; and advisory services. The Healthcare Business segment engages in medical and healthcare services; hospital operation; import, export, and domestic trading of medical-related goods; equipment life cycle management; and medical digitalization services. The company is also involved in medical technology services; hospital construction and management services; and medical consulting services. It serves its products to patients, hospitals, medical equipment suppliers, and other public institutions. The company was formerly known as Universal Medical Financial & Technical Advisory Services Company Limited and changed its name to Genertec Universal Medical Group Company Limited in July 2018. Genertec Universal Medical Group Company Limited was founded in 1984 and is headquartered in Beijing, China. Genertec Universal Medical Group Company Limited operates as a subsidiary of China General Technology (Group) Holding Co.,Ltd.
www.umcare.cn21,521
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 5UM.F
View MorePerformance Overview: 5UM.F
Trailing total returns as of 2/14/2025, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 5UM.F
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 5UM.F
View MoreValuation Measures
Market Cap
1.16B
Enterprise Value
7.40B
Trailing P/E
4.56
Forward P/E
0.00
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.71
Price/Book (mrq)
0.46
Enterprise Value/Revenue
4.19
Enterprise Value/EBITDA
16.16
Financial Highlights
Profitability and Income Statement
Profit Margin
16.23%
Return on Assets (ttm)
2.68%
Return on Equity (ttm)
10.75%
Revenue (ttm)
13.2B
Net Income Avi to Common (ttm)
2.06B
Diluted EPS (ttm)
0.1300
Balance Sheet and Cash Flow
Total Cash (mrq)
2.55B
Total Debt/Equity (mrq)
227.36%
Levered Free Cash Flow (ttm)
--